The governor of New Mexico can be heard saying on a newly leaked recording that she was “offended” when the secretary of the U.S. Department of Homeland Security (DHS) reacted to her concern about a recent surge in Customs and Border Protection (CBP) seizures of marijuana from state-licensed businesses in her state by saying, “Who cares?... Continue Reading →
‘Home-made Cannabis retro sweets’ found after suspect tries to flee police on electric scooter
'Home-made Cannabis retro sweets' found after suspect tries to flee police on electric scooter Image Cannabis News April 25, 2024 Police Seize Cannabis-Infused Retro Sweets in North Down and Ards. The PSNI have seized a bunch of “seemingly home-made cannabis-infused retro sweets”. Police in North Down and Ards made the announcement on their Facebook page.... Continue Reading →
Massachusetts Cannabis sales break records on 4/20
Massachusetts Cannabis sales break records on 4/20 Image Cannabis News April 25, 2024 The state’s cannabis industry had a record-breaking day last week. The Cannabis Control Commission announced that on April 20th, or 4/20, the industry combined for about $8.5 million in sales. There are over 600 operating marijuana establishments in the Commonwealth and they’ve... Continue Reading →
Seed-to-Success Cannabis program providing free training to Cannabis entrepreneurs
Seed-to-Success Cannabis program providing free training to Cannabis entrepreneurs Image Cannabis News April 25, 2024 Free Cannabis Growing Course Draws Over 100 Participants in New York. More than 100 New Yorkers have completed a free two-day cannabis growing course that covers regulatory and workforce education in addition to cultivation, as the person behind the course... Continue Reading →
Congress Will Not Pursue Marijuana Banking Reform Through Must-Pass Aviation Bill, Industry Group Says
Congressional lawmakers have abandoned plans to pursue a marijuana banking bill through unrelated must-pass aviation legislation, determining that it’s “insufficiently germane,” according to a top industry association that cited sources familiar with the decision. That might come as unwelcome news for supporters, including stakeholders who were alerted to the development by an internal U.S. Cannabis... Continue Reading →
JAMA Psychiatry: “No Evidence” That Marijuana Legalization Laws Encourage Youth Use
Neither the passage of adult-use marijuana legalization laws nor the advent of retail cannabis sales is associated with increased marijuana use by adolescents, according to data published this week in JAMA (Journal of the American Medical Association) Psychiatry. Researchers from Montana State University and San Diego State University assessed the relationship between state-level marijuana legalization... Continue Reading →
Kansas Senate Rejects Motion To Revive Medical Marijuana Legalization Bill
The Kansas Senate has rejected a motion to revive a medical marijuana legalization bill after a GOP member forced a vote on the issue. The chamber struck down the motion to take up the bill from Sen. Robert Olson (R) in a 12-25 vote on Friday. This comes weeks after a legislative committee shot down... Continue Reading →
Biden Campaign Says Trump ‘Took Marijuana Reform Backwards’ By Rescinding Enforcement Memo, Despite Current Admin Failing To Reinstate It
The Biden reelection campaign says the Trump administration “took marijuana reform backwards” by rescinding Justice Department guidance that promoted discretion in federal cannabis prosecutions. In an email distributed on Thursday, the Biden-Harris campaign touted the vice president’s White House roundtable with recent pardon recipients who received clemency for drug-related convictions and contrasted various criminal justice... Continue Reading →
Core brands drive record growth for Indiva Limited in 2023
Canadian edibles maker Indiva Limited (TSX: NDVA) reported record financials for the fourth quarter and year ending Dec. 31, 2023, as it tries to climb its way out of the red. The company posted record net revenue of $10.9 million in the fourth quarter of 2023, a 16.8% rise versus the same period in the previous... Continue Reading →
Mydecine will restate 2022 financials, lowering cash levels even further
Mydecine Innovations Group Inc. (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) will restate its previously filed audited financial statements for the fiscal year ended Dec. 31, 2022. Mydecine said the changed financials would result in a lower cash position and increased debts and expenses. Mydecine also said it applied to the British Columbia Securities Commission for... Continue Reading →